CytomX Therapeutics, Inc. - Special Call Transcript
Good day, ladies and gentlemen, and welcome to the CytomX Therapeutics review of ASCO20 Virtual Scientific Program presentations. (Operator Instructions) As a reminder, this call will be recorded. I would now like to introduce your host for today's conference, Christopher Keenan, Vice President of Investor Relations. Chris, you may begin.
Thank you, Andrew. Good afternoon, and thank you all for joining. This morning, we issued a press release highlighting the 7 presentations made by CytomX and our partners as part of the Annual Society of Clinical Oncology's ASCO20 Virtual Scientific Program. The press release can be found under the Investors and News section of our website at cytomx.com, as will also be a recording of this call. During today's call, we will be making forward-looking statements. Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks that are difficult to predict and many of which are outside of our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
